AERI
Aerie Pharmaceuticals
AERI
AERI
Delisted
AERI was delisted on the 18th of November, 2022.
172 hedge funds and large institutions have $1.81B invested in Aerie Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 61 increasing their positions, 55 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
9% more funds holding
Funds holding: 158 → 172 (+14)
20% less call options, than puts
Call options by funds: $8.78M | Put options by funds: $10.9M
Holders
172
Holding in Top 10
9
Calls
$8.78M
Puts
$10.9M
Top Buyers
| 1 | +$70.9M | |
| 2 | +$40.3M | |
| 3 | +$23.9M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$22.2M |
| 5 |
SAM
Senzar Asset Management
New York
|
+$20.6M |
Top Sellers
| 1 | -$65.7M | |
| 2 | -$36.3M | |
| 3 | -$32.2M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$17.2M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$14.3M |